Sosa Maria Soledad
Division of Hematology and Oncology; Department of Medicine; Icahn School Medicine at Mount Sinai; New York, NY USA; Tisch Cancer Institute, Mount Sinai School of Medicine; New York, NY USA.
Mol Cell Oncol. 2015 Apr 14;3(1):e1029062. doi: 10.1080/23723556.2015.1029062. eCollection 2016 Jan.
We recently published that the retinoid-responsive gene NR2F1 (nuclear receptor subfamily 2, group F, member 1) mediates postsurgical dormancy of local residual tumor cells and disseminated tumor cells. Importantly, the combination of azacytidine with retinoids induces dormancy of malignant tumor cells by reinstating the NR2F1-regulated gene program. These findings open the door to the development of strategies that may stop minimal residual disease from becoming life-threatening metastases.
我们最近发表了一项研究,指出类视黄醇反应基因NR2F1(核受体亚家族2,F组成员1)介导局部残留肿瘤细胞和播散性肿瘤细胞的术后休眠。重要的是,阿扎胞苷与类视黄醇联合使用可通过恢复NR2F1调控的基因程序来诱导恶性肿瘤细胞休眠。这些发现为开发可能阻止微小残留病发展为危及生命的转移瘤的策略打开了大门。